HAL vs PMCB
Halliburton Company (HAL) versus PharmaCyte Biotech Inc (PMCB) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
PharmaCyte Biotech Inc (PMCB) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported PMCB revenue for 2025-04-30 was $0. Net income was $30.7M. PMCB currently screens at market cap $8.6M.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. PMCB currently screens at market cap $8.6M.
Not investment advice. Open the HAL and PMCB stock pages for the full models.
Not investment advice.